Anti-miRNA103/107 encapsulated in transferrin-conjugated lipid nanoparticles crosses blood-brain barrier and reduces brain ischemic damage-Reference-Cited by-同舟云学术

Anti-miRNA103/107 encapsulated in transferrin-conjugated lipid nanoparticles crosses blood-brain barrier and reduces brain ischemic damage

Published:2024-03 Issue:1 Volume:35 Page:102131
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Cepparulo Pasquale,Cuomo Ornella,Campani Virginia,Vinciguerra Antonio,Sisalli Maria Josè,Nele Valeria,Anzilotti Serenella,Valsecchi Valeria,Casamassa Antonella,Brancaccio Paola,Scorziello Antonella,De Rosa Giuseppe,Annunziato Lucio,Pignataro Giuseppe^ORCID

Funder

MIUR

Publisher

Elsevier BV

Reference28 articles.

1. Effect of intravenous recombinant tissue plasminogen activator on ischemic stroke lesion size measured by computed tomography. NINDS; The National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Study Group;Stroke,2000

2. MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration;Saugstad;J. Cerebr. Blood Flow Metabol.,2010

3. MicroRNA-based therapeutics in central nervous system injuries;Sun;J. Cerebr. Blood Flow Metabol.,2018

4. Selective inhibition of miRNA processing by a herpesvirus-encoded miRNA;Hennig;Nature,2022

5. Widespread changes in protein synthesis induced by microRNAs;Selbach;Nature,2008

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid engineered nanomaterials: A novel paradigm shift for combating stroke;Applied Materials Today;2024-06

2. Epigenetic and nanotechnology alliance to fight stroke-induced brain damage;Molecular Therapy - Nucleic Acids;2024-03